Smart Life Sciences Manufacturing Market Report 2026

Smart Life Sciences Manufacturing Market Overview

• Smart Life Sciences Manufacturing market size has reached to $28.59 billion in 2025 • Expected to grow to $59.21 billion in 2030 at a compound annual growth rate (CAGR) of 15.9% • Growth Driver: Rising Demand For Personalized Medicine Drives Growth In The Smart Life Sciences Manufacturing Market • Market Trend: Innovation In Smart Life Sciences Manufacturing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Smart Life Sciences Manufacturing Market?

Smart life sciences manufacturing is a technology-driven strategy to monitor the production process in the life sciences business using Internet-connected gear. It is used to find opportunities for automating activities and to improve industrial performance through data analytics. The main components of smart life sciences manufacturing are solutions and services. A solution component refers to a distinct and essential part or element within a larger solution or system. It includes various technologies, such as augmented reality and virtual reality systems, the Internet of Things (IoT), artificial intelligence, cybersecurity, big data, and others. These are used for several applications, including pharmaceuticals, biopharmaceuticals, and medical devices.

What Is The Smart Life Sciences Manufacturing Market Growth Forecast?

The smart life sciences manufacturing market size is expected to see rapid growth in the next few years. It will grow to $59.21 billion in 2030 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to increasing investments in smart pharma factories, rising adoption of digital twin technologies, expansion of personalized medicine manufacturing, growing integration of AI-driven quality analytics, increasing focus on supply chain visibility and resilience. Major trends in the forecast period include increasing adoption of digital manufacturing execution systems, rising integration of iot-enabled production monitoring, growing use of advanced data analytics for process optimization, expansion of automation and robotics in pharma manufacturing, enhanced focus on regulatory compliance and quality control.

Global Smart Life Sciences Manufacturing Market Segmentation

1) By Component: Solution, Services 2) By Technology: Internet of Things (IoT), Artificial Intelligence, Cybersecurity, Big Data, Other Technologies 3) By Application: Pharma, Bio-Pharma, Medical Device Subsegments: 1) By Solution: Manufacturing Execution Systems (MES), Quality Management Systems (QMS), Automation and Control, Data Analytics And Reporting 2) By Services: Consulting Services, Integration And Implementation, Maintenance and Support

What Is The Driver Of The Smart Life Sciences Manufacturing Market?

Rising demand for personalized medicine is expected to propel the growth of the smart life sciences manufacturing market going forward. Personalized medicine refers to an approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and therapies to individual patients. Rising demand for personalized medicine is pushing the life sciences industry to adopt smart manufacturing technologies and processes to enable efficient, precise, and flexible production of customized pharmaceuticals and therapies and improve treatment outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the rising demand for personalized medicine is driving the growth of the smart life sciences manufacturing industry.

Key Players In The Global Smart Life Sciences Manufacturing Market

Major companies operating in the smart life sciences manufacturing market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Novartis AG, Merck and Co Inc, Sanofi S A, GlaxoSmithKline plc, AstraZeneca plc, Bristol Myers Squibb, Eli Lilly and Company, AbbVie Inc, Amgen Inc, Gilead Sciences Inc, Biogen Inc, Takeda Pharmaceutical Company Limited, Bayer AG, Boehringer Ingelheim, Novo Nordisk A S, Teva Pharmaceutical Industries Ltd, CSL Limited

Global Smart Life Sciences Manufacturing Market Trends and Insights

Major market players are concentrating their efforts on creating innovative AI (artificial intelligence) medical technologies to sustain their position in the market. AI-based advancements are needed in smart life science to analyze and interpret vast amounts of data, streamline processes, and enable more personalized engagement. For instance, in May 2023, Google Cloud Platform LLC, a US-based technology company, launched two new AI-powered solutions to accelerate drug discovery and precision medicine. This innovative tool can help researchers discover new drugs faster and more efficiently. Additionally, these tools can help improve the accuracy of drug development and reduce the cost of bringing new drugs to market. Moreover, it has the potential to accelerate the growth of new drugs and improve patients' lives.

What Are Latest Mergers And Acquisitions In The Smart Life Sciences Manufacturing Market?

In March 2024, Ingersoll Rand Inc., a US-based provider of industrial and precision technologies, acquired ILC Dover for approximately US $2.325 billion. Through this acquisition, Ingersoll Rand aims to expand its presence in the life sciences manufacturing market by integrating ILC Dover’s single-use powder and liquid containment solutions and advanced components for biopharmaceutical and medical device production. ILC Dover is a US-based company that provides engineered solutions for biopharma, pharmaceutical, and medical device manufacturing, including single-use containment systems and specialty components.

Regional Insights

North America was the largest region in the smart life sciences manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Smart Life Sciences Manufacturing Market?

The smart life sciences manufacturing includes revenues earned by entities by providing services such as process automation and integration, supply chain optimization, bioprocessing solutions, process optimization, digital twin implementation and robotics integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart life sciences manufacturing market also includes sales of manufacturing execution systems, robotic systems, laboratory automation equipment, real-time monitoring devices and Internet of Things (IoT) devices that are used in providing smart life sciences manufacturing. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Smart Life Sciences Manufacturing Market Report 2026?

The smart life sciences manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the smart life sciences manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.